Sarepta Therapeutics Stock Price Patterns
| SRPT Stock | USD 18.34 0.03 0.16% |
Momentum 52
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 26.638 | EPS Estimate Next Quarter (0.64) | EPS Estimate Current Year (1.99) | EPS Estimate Next Year 3.099 | Wall Street Target Price 21.4348 |
Using Sarepta Therapeutics hype-based prediction, you can estimate the value of Sarepta Therapeutics from the perspective of Sarepta Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Sarepta Therapeutics using Sarepta Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Sarepta using crowd psychology based on the activity and movement of Sarepta Therapeutics' stock price.
Sarepta Therapeutics Short Interest
An investor who is long Sarepta Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Sarepta Therapeutics and may potentially protect profits, hedge Sarepta Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 24.1995 | Short Percent 0.2354 | Short Ratio 7.12 | Shares Short Prior Month 20.5 M | 50 Day MA 21.392 |
Sarepta Therapeutics Hype to Price Pattern
Investor biases related to Sarepta Therapeutics' public news can be used to forecast risks associated with an investment in Sarepta. The trend in average sentiment can be used to explain how an investor holding Sarepta can time the market purely based on public headlines and social activities around Sarepta Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Sarepta Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Sarepta Therapeutics.
Sarepta Therapeutics Implied Volatility | 1.12 |
Sarepta Therapeutics' implied volatility exposes the market's sentiment of Sarepta Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Sarepta Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Sarepta Therapeutics stock will not fluctuate a lot when Sarepta Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Sarepta Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Sarepta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sarepta Therapeutics after-hype prediction price | USD 18.47 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Sarepta contract
Based on the Rule 16, the options market is currently suggesting that Sarepta Therapeutics will have an average daily up or down price movement of about 0.07% per day over the life of the 2026-05-15 option contract. With Sarepta Therapeutics trading at USD 18.34, that is roughly USD 0.0128 . If you think that the market is fully incorporating Sarepta Therapeutics' daily price movement you should consider acquiring Sarepta Therapeutics options at the current volatility level of 1.12%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Sarepta Therapeutics Basic Forecasting Models to cross-verify your projections. Sarepta Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Sarepta Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sarepta Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sarepta Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sarepta Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Sarepta Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sarepta Therapeutics' historical news coverage. Sarepta Therapeutics' after-hype downside and upside margins for the prediction period are 13.93 and 23.01, respectively. We have considered Sarepta Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sarepta Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Sarepta Therapeutics is based on 3 months time horizon.
Sarepta Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Sarepta Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sarepta Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sarepta Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 4.54 | 0.11 | 0.01 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
18.34 | 18.47 | 0.87 |
|
Sarepta Therapeutics Hype Timeline
Sarepta Therapeutics is at this time traded for 18.34. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.01. Sarepta is projected to increase in value after the next headline, with the price projected to jump to 18.47 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 0.87%, whereas the daily expected return is at this time at 0.13%. The volatility of related hype on Sarepta Therapeutics is about 11641.03%, with the expected price after the next announcement by competition of 18.35. The company reported the previous year's revenue of 1.9 B. Net Income was 235.24 M with profit before overhead, payroll, taxes, and interest of 443.83 M. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Sarepta Therapeutics Basic Forecasting Models to cross-verify your projections.Sarepta Therapeutics Related Hype Analysis
Having access to credible news sources related to Sarepta Therapeutics' direct competition is more important than ever and may enhance your ability to predict Sarepta Therapeutics' future price movements. Getting to know how Sarepta Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sarepta Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RXRX | Recursion Pharmaceuticals | 0.23 | 7 per month | 0.00 | (0.08) | 7.87 | (5.83) | 20.15 | |
| AGIO | Agios Pharm | (0.08) | 10 per month | 0.00 | (0.05) | 5.99 | (3.94) | 56.88 | |
| BEAM | Beam Therapeutics | 0.28 | 11 per month | 3.50 | 0.06 | 8.12 | (6.30) | 31.78 | |
| COGT | Cogent Biosciences | (0.47) | 7 per month | 1.81 | 0.14 | 5.71 | (4.39) | 126.24 | |
| DNLI | Denali Therapeutics | 0.13 | 12 per month | 2.98 | 0.12 | 6.50 | (4.22) | 23.32 | |
| ETNB | 89bio Inc | (0.01) | 6 per month | 1.83 | 0.09 | 3.02 | (4.66) | 86.02 | |
| RCUS | Arcus Biosciences | 0.01 | 9 per month | 4.40 | 0.01 | 5.64 | (6.53) | 19.63 | |
| ADPT | Adaptive Biotechnologies Corp | 0.06 | 10 per month | 0.00 | (0.03) | 9.94 | (6.49) | 29.55 | |
| IBRX | Immunitybio | 0.14 | 9 per month | 3.83 | 0.25 | 14.55 | (7.11) | 51.87 | |
| MLYS | Mineralys Therapeutics Common | 0.1 | 9 per month | 0.00 | (0.09) | 6.62 | (6.42) | 24.91 |
Sarepta Therapeutics Additional Predictive Modules
Most predictive techniques to examine Sarepta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sarepta using various technical indicators. When you analyze Sarepta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sarepta Therapeutics Predictive Indicators
The successful prediction of Sarepta Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sarepta Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sarepta Therapeutics based on analysis of Sarepta Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sarepta Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sarepta Therapeutics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 128.28 | 124.69 | 112.22 | 121.8 | PTB Ratio | 10.37 | 7.57 | 8.7 | 6.75 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sarepta Stock Analysis
When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.